Huntington Disease - Pipeline Review, H1 2016 published by Global Markets Direct now available at Zursh

San Diego: This report provides comprehensive information on the therapeutic development for Huntington Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

The report also reviews key players involved in the therapeutic development for Huntington Disease) and special features on late-stage and discontinued projects.The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Table of Contents

  1. Introduction
  2. Huntington Disease Overview
  3. Therapeutics Development
  4. Pipeline Products for Huntington Disease - Overview
  5. Pipeline Products for Huntington Disease - Comparative Analysis
  6. Huntington Disease - Therapeutics under Development by Companies
  7. Huntington Disease - Therapeutics under Investigation by Universities/Institutes
  8. Huntington Disease Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Huntington Disease - Products under Development by Companies
  13. Huntington Disease - Products under Investigation by Universities/Institutes
  14. Huntington Disease - Companies Involved in Therapeutics Development
Companies Involved in Therapeutics Development:
  • Addex Therapeutics Ltd
  • AFFiRiS AG
  • Angita B.V.
  • Astellas Pharma Inc.
  • Azevan Pharmaceuticals, Inc.
  • BioCrea GmbH
  • BioMarin Pharmaceutical Inc.
  • BrainStorm Cell Therapeutics Inc.
  • Diffusion Pharmaceuticals Inc.
  • EncephRx, Inc.
  • Evotec AG
  • Galenea Corp.
  • Genervon Biopharmaceuticals, LLC
  • Immungenetics AG
  • Ionis Pharmaceuticals, Inc.
  • Ipsen S.A.
  • Kadmon Corporation, LLC
  • KineMed, Inc.
  • Living Cell Technologies Limited
  • Medesis Pharma S.A.
  • Mitochon Pharmaceuticals, Inc.
  • Neuralstem, Inc.
  • Neurimmune Holding AG
  • NeuroNascent, Inc.
  • New World Laboratories, Inc.
  • nLife Therapeutics, S.L.
  • NsGene A/S
  • Omeros Corporation
  • Oryzon Genomics S.A.
  • Otsuka Holdings Co., Ltd.
  • Pfizer Inc.
  • PharmatrophiX, Inc.
  • ProQR Therapeutics N.V.
  • QR Pharma, Inc.
  • Raptor Pharmaceutical Corp.

Please find more about Huntington Disease - Pipeline Review, H1 2016 at reports.zursh.com

Click on below items to see free updates about the topic covered.

Industry Updates

Click on below items to see free resources and reports about the topic covered.

Free Resources

Contact Information

Simon Sliman
Simon Sliman (write to Simon)
Research Manager
Zursh Inc. www.zursh.com | reports.zursh.com
Email: reports(at)zursh(dot)com
Lloyd Chambers
Lloyd Chambers (write to Lloyd)
Research Manager
Zursh Inc. www.zursh.com | reports.zursh.com
Email: reports(at)zursh(dot)com

Free Research Updates

Get Latest Updates Completely Free When New Research in Your Industry is Released

Free Research Updates

Get Latest Updates Completely Free When New Research in Your Industry is Released

*We Don't Spam